COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:
Stockwire.com: Speak with other shareholders about: (OTCBB: MSBT), (OTCBB: SLWF), (OTCBB: WDWT), (OTCBB: MGEN)
May 01, 2007 (M2 PRESSWIRE via COMTEX) -- AUSTIN, TX: A very interesting indicator to look for is where the money is flowing into. We have a filter that we watch every morning that shows us "Dollar Volume". Here are a few of these stocks: MedaSorb Technologies Corporation (OTCBB: MSBT), Seamless Wi-Fi, Inc. (OTCBB: SLWF), World Waste Technologies, Inc. (OTCBB: WDWT), Med Gen Inc. (OTCBB: MGEN)
Have you ever watched a STOCKUMENTARY? Click the following link to view your first ever full length STOCKUMENTARY:
www.stockwire.com/cdrom/streaming_flash_page.htm .
--------------------------------------------------
Would you like to hear your favorite CEO interviewed on Stockwire.com? If so, send them an email letting them know it's available to them at NO COST!
Talk to other MSBT shareholders by clicking the following link:
www.stockwire.com/talkback?MSBT .
To view in-depth research, click the following link:
www.stockwire.com/detailed/analysis.php?company=MSBT .
MedaSorb Technologies Corporation (OTCBB: MSBT) MedaSorb Technologies Corporation a medical device company that engages in the research and development of an adsorbent platform technology for removal of toxins from blood and physiologic fluids, is pleased to announce that its shares are now listed for trading on the Frankfurt Stock Exchange, effective immediately. MedaSorb's trading symbol on the Frankfurt Exchange is HQE.FSE and its WKN (German Security Code) is
A0KEY3.
"Listing on the Frankfurt Exchange will allow current and potential European shareholders of MedaSorb to trade our shares within the European time zones and in local currency. This will increase our corporate profile with both private and institutional investors in Germany and across Europe," said Al Kraus, MedaSorb CEO. "This opportunity is part of our strategy to develop synergy between a global shareholder base and the commercialization of our potential products." Shares traded on the Frankfurt Stock Exchange do not have an effect on MedaSorb's total shares outstanding.
Would you like to hear your favorite CEO interviewed on Stockwire.com? If so, send them an email letting them know it's available to them at NO COST!
Talk to other SLWF shareholders by clicking the following link:
www.stockwire.com/talkback?SLWF .
To view in-depth research, click the following link:
www.stockwire.com/detailed/analysis.php?company=SLWF .
Seamless Wi-Fi, Inc.
(OTCBB: SLWF) Seamless Wi-Fi, Inc. s subsidiary Seamless Internet, Inc. announced today that X 1.0, a leading solution provider in the New York metro area, has increased its S-XGen(TM) order by an additional 1,500 units, for a total order of 2,000 units ordered by X 1.0. Seamless Internet has now received orders for over 12,000 S-XGen(TM) units overall. Nathan Archer, President of X 1.0, stated, "I presented the S-XGen at the Government XChange Conference in Washington, D.C. last week, and the response was overwhelming. We received requests from several system integrators to allow them to carry the S-XGen UMPC to their diverse vertical markets, including seeking to have the product line placed on a GSA Schedule to offer it to First Responders during critical situations." Mr. Archer continued, "This is an increase of our initial 500-unit order that was necessary after delivering the sample units to clients that placed initial orders for the S-XGen. The positive reaction of our solution providers gives us a very good indication of the market desire and true potential for this unit." John Domerego, President of Seamless Internet, stated, "We are pleased with the developing relationship with X 1.0 and with how their clients are receiving the S-XGen. We are now focused on filling the 12,000 unit orders we have in place and look forward to building upon the momentum already generated for our device."
To find out more about Seamless Wi-Fi, Inc. visit:
www.slwf.net and
www.seamlessinternet.com Would you like to hear your favorite CEO interviewed on Stockwire.com? If so, send them an email letting them know it's available to them at NO COST!
Talk to other WDWT shareholders by clicking the following link:
www.stockwire.com/talkback?WDWT .
To view in-depth research, click the following link:
www.stockwire.com/detailed/analysis.php?company=WDWT .
World Waste Technologies, Inc.
(Pink sheets & OTCBB: WDWT) World Waste Technologies and Ensyn Corporation announced yesterday that they have entered into a memorandum of understanding relating to a proposed technology research and development arrangement under which the companies would collaborate to develop technologies for production of energy products and bio-fuels from cellulose biomass derived from post-recycling municipal solid waste.
For more information about World Waste Technologies contact: John Pimentel, CEO +1-858-391-3400
Would you like to hear your favorite CEO interviewed on Stockwire.com? If so, send them an email letting them know it's available to them at NO COST!
Talk to other WDWT shareholders by clicking the following link:
www.stockwire.com/talkback?WDWT .
To view in-depth research, click the following link:
www.stockwire.com/detailed/analysis.php?company=WDWT .
Med Gen Inc.
(OTCBB: MGEN) Med Gen Inc. manufacturers of nationally branded OTC healthier life products (best known for producing the world's first patented liquid spray snoring relief formula, Snorenz(R) ), announced yesterday it has formed a joint venture (JV) with Foot Fridge(R) a wholly owned subsidiary of Fit For Business International (OTCBB:FFBU). "Foot Fridge(R) holds the patent for an extraordinary product that cools the feet, reduces swelling and promotes foot comfort. It might also be helpful to Type 2 Diabetics that experience burning feet," said Paul Kravitz, Med Gen Chairman & CEO. The company reports that the deal comes with all the bells and whistles in place, commercial already made and ready to go. Thus testing the product will be cost effective...and if it rings the phone, there will be millions of dollars to split between the two public companies. "We have done our homework," said Paul Mitchell, company President. "This is a $40 billion market. We are going to test in New York City first, a walking city. If it works there, we will go full blast into every walking city in the USA. These are exciting times for Med Gen, we are really building our revenues and our company quickly. TV commercials are running on UnDiet(R), we are in production on a TV commercial for Painenz(R), entitled Rub-On-Pain-enz(R) and, we await packaging for FabULust(R) and Good Nights Sleep(R) all natural."
--------------------------------------------------
As a trader, a very intelligent place to put your money, is where the money is flowing into. These are the kind of trades that you want to get into.
As the saying goes...follow the money!
To see the complete Movers & Shakers Blog go to:
www.stockwire.com .
About Stockwire: Stockwire is a company that is pioneering a new way to research companies before you invest them. It's called a Stockumentary. A Stockumentary is a documentary on a publicly traded company. Imagine a Dateline NBC segment, but on a publicly traded company. We are the first company to ever bring this type of quality research to investors in this format.
The Stockumentary has video interviews with management, product demos, video tours of office or factory, research reports, sec filings and much more. All of this is delivered to investors in high quality video, either by mail or email.
Stockwire.com is owned by Stockwire Research Group Inc. (SRGI) and is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies.
As detailed below, this publication accepts compensation from some of the companies from which it features. To the degrees listed herein, this Newsletter should not be regarded as an independent publication. All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the Newsletter is neither an offer nor solicitation to buy or sell any securities mentioned.
While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
We encourage our readers to invest carefully and read the investor information available at the web sites of the Securities and Exchange Commission ("SEC") at
www.sec.gov and/or the National Association of Securities Dealers ("NASD") at
www.nasd.com. The NASD has published information on how to invest carefully at its web site.
Readers can review all public filings by companies at the SEC's EDGAR page.
www.sec.gov/edgar.shtml Stockwire.com is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. Stockwire.com is not a registered investment advisor or broker-dealer. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible.
From time to time SRGI sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies.
Moreover, as detailed below, this publication accepts compensation from third party consultants and/or companies which it features on Stockwire.com. Likewise, Stockwire.com is owned by Stockwire Research Group Inc. (SRGI). To the degrees enumerated herein, this newsletter and website should not be regarded as an independent publication.
All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company on Stockwire.com is neither an offer nor solicitation to buy or sell any securities mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.
The editor, members of the editor's family, and/or entities with which the editor is affiliated aside from Stockwire Research Group Inc. (SRGI) itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF STOCKWIRE.COM.
We often accept restricted shares of company stock; by SEC regulations, restricted shares cannot be sold into the market for a period of at least one year from the time that the shares are issued. In such cases, we detail in the Disclaimer the specific term of any restrictions. We also receive compensation in the form of stock options, in which case we receive the right to buy shares of the stock of the company at issue, at a specified time and a specified price. In such circumstances, we specify on our Disclaimer the terms of the options received. On occasion, we also accept free-trading shares in a company that we cover. However, by policy we generally do not buy or sell any shares of a company's stock within three trading days after any such company's profile, commentary, or other company-specific information is disseminated on Stockwire.com Web site. In cases where we do trade within the three day window, our volume will never represent more than 5% of the daily volume, thereby minimizing any effect we could have on the potential price movement.
While our policies as detailed above are designed to minimize any impact upon our members of a conflict of interest between our company and our members, each member should be fully aware that such potential and actual conflicts of interest may well exist due to the compensation structure detailed herein. For this reason, and because the information contained on Stockwire.com is updated on a regular basis as circumstances change, each member is strongly encouraged to periodically review the Profile Compensation section at
www.stockwire.com/disclaimer_profiles.htm CONTACT: Stockwire Research Group, Inc. Tel: +1 512 358 8440 e-mail: info@stockwire.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at
www.presswire.net on the world wide web. Inquiries to info@m2.com.
(C)1994-2007 M2 COMMUNICATIONS LTD
-0-
Search for Dun & Bradstreet reports on this company.